EUVIMEDEUVIMED entdecken
Crossref

Magnetic resonance imaging-based radiomics for predicting infiltration levels of CD68+ tumor-associated macrophages in glioblastomas

Qing Zhou, Bin Zhang, Caiqiang Xue, Jialiang Ren, Peng Zhang, Xiaoai Ke, Jiangwei Man, Junlin Zhou iD

Strahlentherapie und Onkologie · 2025

DOI: 10.1007/s00066-024-02289-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Strahlentherapie und Onkologie, 2025. Verfasst von Qing Zhou und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Lanzhou University Second Hospital, Cuiyingmen No.82, Chengguan District, 730030, Lanzhou, Gansu, China. Hauptthemen laut MEDLINE: Glioblastoma, Magnetic Resonance Imaging, Antigens, Differentiation, Myelomonocytic, Brain Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Science and Technology Program of Gansu Province, Cuiying Science and Technology Innovation Program of Lanzhou University Second Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Tumor-associated macrophages (TAMs) are important biomarkers of tumor invasion and prognosis in patients with glioblastoma. We combined the imaging and radiomics features of preoperative MRI to predict CD68+ macrophage infiltration. METHODS: Clinical, MRI image, and pathology data of 188 patients with glioblastoma were analyzed. Overall, 143 patients were included in the training (n = 101) and validation (n = 42) sets, whereas 45 patients were included in an independent test set. The optimal cut-off value (14.8%) was based on the minimum p-value formed by the Kaplan-Meier survival analysis and log-rank tests which divided patients into groups with high CD68+ TAMs (≥ 14.8%) and low CD68+ TAMs (< 14.8%). Regions of interest and radiomics features extraction were based on contrast-enhanced T1-weighted images (CE-T1WI) and T2WI. Multi-parameter stepwise regression was used to create the clinical, radiomics, and combined models, each evaluated using the receiver operating characteristic curve. Decision curve analysis was used to assess the clinical applicability of the nomogram. RESULTS: A clinical model based on the minimum apparent diffusion coefficient (ADCmin) revealed an area under the curve (AUC) of 0.768, 0.764, and 0.624 for the training set, validation set, and test set, respectively. The 2D radiomics model, based on two features, revealed an AUC of 0.783, 0.724, and 0.789 for the training, validation, and test sets, respectively. The 3D radiomics model, based on three features, revealed AUCs of 0.823, 0.811, and 0.787 for the training, validation, and test sets, respectively. The combined model, with ADCmin and radiomics features, showed the best performance, with AUCs of 0.865, 0.822, and 0.776 for the training, validation, and test sets, respectively. The calibration curve of the combined model nomogram showed good agreement between the estimated and actual probabilities. CONCLUSION: The combined model constructed using ADCmin, a quantitative imaging parameter, combined with five key radiomics features can be used to evaluate the extent of CD68+ macrophages before surgery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaMagnetic Resonance ImagingAntigens, Differentiation, MyelomonocyticBrain NeoplasmsAntigens, CDTumor-Associated MacrophagesHumansMaleFemaleMiddle AgedAdultAgedPrognosisNeoplasm InvasivenessRadiomicsCD68 Molecule

Stichwörter der Autor:innen

GlioblastomaPrediction modelRadiomicsTumor microenvironmentTumor-associated macrophages

Substanzen

Antigens, Differentiation, MyelomonocyticAntigens, CDCD68 antigen, humanCD68 Molecule

Autor:innen und Institutionen

  • Department of Radiology, Lanzhou University Second Hospital, Cuiyingmen No.82, Chengguan District, 730030, Lanzhou, Gansu, China.
  • Gansu International Scientific and Technological Cooperation Base of Medical Imaging Artificial Intelligence, Lanzhou, Gansu, China.
  • Second Clinical School, Lanzhou University, Lanzhou, Gansu, China.
  • GE Healthcare, Beijing, China.
  • Department of Pathology, Lanzhou University Second Hospital, Lanzhou, Gansu, China.
  • Department of Surgical, Lanzhou University Second Hospital, Lanzhou, Gansu, China.

ORCID-Profile: Junlin Zhou

Förderung

  • National Natural Science Foundation of China
  • Science and Technology Program of Gansu Province
  • Cuiying Science and Technology Innovation Program of Lanzhou University Second Hospital

Zitieren

APA

Zhou, Q., Zhang, B., Xue, C., Ren, J., Zhang, P., Ke, X., Man, J., & Zhou, J. (2025). Magnetic resonance imaging-based radiomics for predicting infiltration levels of CD68+ tumor-associated macrophages in glioblastomas. Strahlentherapie und Onkologie. https://doi.org/10.1007/s00066-024-02289-5

Vancouver

Zhou Q, Zhang B, Xue C, Ren J, Zhang P, Ke X, et al. Magnetic resonance imaging-based radiomics for predicting infiltration levels of CD68+ tumor-associated macrophages in glioblastomas. Strahlentherapie und Onkologie. 2025. doi:10.1007/s00066-024-02289-5

BibTeX
@article{Zhou2025,
  author = {Zhou, Qing and Zhang, Bin and Xue, Caiqiang and Ren, Jialiang and Zhang, Peng and Ke, Xiaoai and Man, Jiangwei and Zhou, Junlin},
  title = {Magnetic resonance imaging-based radiomics for predicting infiltration levels of CD68+ tumor-associated macrophages in glioblastomas},
  journal = {Strahlentherapie und Onkologie},
  year = {2025},
  doi = {10.1007/s00066-024-02289-5}
}
Kostenlos starten →